News
Felix Bayerl is a post-doctoral fellow in Professor Mikaël Pittet's laboratory in the Department of Pathology and Immunology ...
Investigators led by Navdeep Chandel, Ph.D., the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and ...
In fighting chronic infections or certain cancers, CD8+ T cells—the immune system's frontline soldiers—eventually become ...
Researchers have discovered a way to make the immune system’s T cells significantly more effective at fighting cancer. By ...
Despite challenges in studying allergen-specific CD4+ T cells in food allergy, targeted approaches signal progress while ...
Hosted on MSN23d
Uncovering the mechanisms behind T cell differentiationHowever, scientists haven't fully understood whether infected tissue itself has any role in directing the optimal T cell differentiation in response to tissue infection.
22d
AZoLifeSciences on MSNReinvigorating T Cells Offers Hope for More Effective Cancer ImmunotherapyCD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the hostile and chronic environment of tumors, these cells often falter.
10d
News-Medical.Net on MSNAPOE ε4 variant reveals hidden risk factors beyond Alzheimer’sResearchers discovered that people carrying the APOE ε4 gene variant share a unique immune-related protein signature across ...
Gut support cells communicate with surprising precision – like brain neurons – using tiny extensions to send instructions to ...
Arcellx, Inc. advances anito-cel CAR-T therapy for relapsed/refractory multiple myeloma. Click for ACLX pivotal trials, FDA progress, and launch potential by 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results